A Bioorthogonal TCO–Tetrazine-Based Pretargeted PET/NIRF Platform Enabling High-Contrast Tumor Imaging
<b>Objectives</b>: Pretargeting strategies enhance the specificity and safety of radiopharmaceuticals by separating tumor targeting from radionuclide delivery. To address the rapid clearance and systemic exposure of directly labeled small-molecule agents, a DZ-1–based pretargeting system was develop...
Guardado en:
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
MDPI AG
2025-12-01
|
| Colección: | Pharmaceuticals |
| Materias: | |
| Acceso en línea: | https://www.mdpi.com/1424-8247/18/12/1874 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|